November 2016 FDA Recall Drug by Mylan Pharmaceuticals Inc.
D-0151-2017 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on November 3, 2016 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0151-2017

Reason for Recall
Failed Impurities/Degradation Specifications: OOS results for known compound.
Initiated
11-03-2016
Reported
11-30-2016
Quantity
51,983 extended release capsules

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Mylan Pharmaceuticals Inc.
Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC 0378-5220-05), Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA

Batch or Lot Expiration Information

Lot# 0378-5220-01
Lot# 3065133; Exp. 03/17 0378-5220-01
Lot# 3066564; Exp. 05/17 0378-5220-05
Lot# 3066564; Exp. 05/17 0378-5220-01
Lot# 3069645; Exp. 08/17 0378-5220-05
Lot# 3069645; Exp. 08/17